Alzheimer's disease is a multi-factorial disease that disrupts many aspects of human
behavior. In this comment, we highlight the work by Koulousakis et al. published in a recent …

Aim We previously reported that oxytocin, a peptide hormone, can reverse the β‐amyloid
peptide (25–35)(Aβ25–35)‐induced impairments of the murine hippocampal synaptic …

Alzheimer's disease (AD) is characterized by neurodegeneration, memory loss, and social
withdrawal. Brain inflammation has emerged as a key pathogenic mechanism in AD. We …

Aim Oxytocin, a peptide hormone synthesized in the hypothalamic paraventricular nucleus,
has been reported to participate in the regulation of learning and memory performance …

Older adults have been neglected in biobehavioral oxytocin research. Emerging research
indicates that oxytocin signaling activity fluctuates over the lifespan, which suggests that …

Background: Current treatment options for Alzheimer's disease (AD) are limited, inefficient,
and often have serious side effects. Oxytocin is a neuropeptide implicated in a variety of …

Oxytocin (oxy) is a pituitary neuropeptide hormone synthesized from the paraventricular and
supraoptic nuclei within the hypothalamus. Like other neuropeptides, oxy can modulate a …

Oxytocin (OXT) is an “affiliative” hormone or neurohormone or neuropeptide consists of nine
amino acids, synthesized in magnocellular neurons of paraventricular (PVN) and supraoptic …

Introduction: Changes in social behavior and emotion processing are common in
frontotemporal dementia (FTD) and semantic dementia (SD), and less so in Alzheimer's …

Although intranasal oxytocin administration to tap into central functions is the most
commonly used non-invasive means for exploring oxytocin's role in human cognition and …